- Home
- KRO vs ORGO Comparison
KRO vs ORGO Comparison
Compare KRO & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRO
- ORGO
- Stock Information
- Founded
- KRO 1916
- ORGO 1985
- Country
- KRO United States
- ORGO United States
- Employees
- KRO N/A
- ORGO N/A
- Industry
- KRO Major Chemicals
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- KRO Industrials
- ORGO Health Care
- Exchange
- KRO Nasdaq
- ORGO Nasdaq
- Market Cap
- KRO 503.9M
- ORGO 539.1M
- IPO Year
- KRO N/A
- ORGO N/A
- Fundamental
- Price
- KRO $5.04
- ORGO $5.14
- Analyst Decision
- KRO Strong Sell
- ORGO Buy
- Analyst Count
- KRO 2
- ORGO 3
- Target Price
- KRO $6.50
- ORGO $8.00
- AVG Volume (30 Days)
- KRO 333.5K
- ORGO 3.1M
- Earning Date
- KRO 11-06-2025
- ORGO 11-06-2025
- Dividend Yield
- KRO 3.91%
- ORGO N/A
- EPS Growth
- KRO N/A
- ORGO N/A
- EPS
- KRO N/A
- ORGO N/A
- Revenue
- KRO $1,864,200,000.00
- ORGO $465,218,000.00
- Revenue This Year
- KRO N/A
- ORGO $2.51
- Revenue Next Year
- KRO $6.29
- ORGO $25.45
- P/E Ratio
- KRO N/A
- ORGO N/A
- Revenue Growth
- KRO 0.01
- ORGO 2.24
- 52 Week Low
- KRO $4.08
- ORGO $2.61
- 52 Week High
- KRO $11.70
- ORGO $7.08
- Technical
- Relative Strength Index (RSI)
- KRO 56.04
- ORGO 50.25
- Support Level
- KRO $4.29
- ORGO $5.09
- Resistance Level
- KRO $4.94
- ORGO $5.83
- Average True Range (ATR)
- KRO 0.22
- ORGO 0.50
- MACD
- KRO 0.08
- ORGO -0.08
- Stochastic Oscillator
- KRO 83.62
- ORGO 3.02
About KRO Kronos Worldwide Inc
Kronos Worldwide Inc manufactures and sells titanium dioxide pigments. Titanium dioxide is a white inorganic pigment used in various products. The majority of Kronos' sales come from titanium dioxide used for coatings on automobiles, aircraft, machines, appliances, traffic paint, and in both commercial and residential interiors and exteriors. The second product category is titanium dioxide used for plastics such as packaging materials and food packaging, houseware, appliances, toys, and computer cases. The majority of revenue comes from the United States.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.